Literature DB >> 29940269

Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease.

Cynthia Lebeaupin1, Deborah Vallée1, Younis Hazari2, Claudio Hetz3, Eric Chevet4, Béatrice Bailly-Maitre5.   

Abstract

The global epidemic of obesity has been accompanied by a rising burden of non-alcoholic fatty liver disease (NAFLD), with manifestations ranging from simple steatosis to non-alcoholic steatohepatitis, potentially developing into hepatocellular carcinoma. Although much attention has focused on NAFLD, its pathogenesis remains largely obscure. The hallmark of NAFLD is the hepatic accumulation of lipids, which subsequently leads to cellular stress and hepatic injury, eventually resulting in chronic liver disease. Abnormal lipid accumulation often coincides with insulin resistance in steatotic livers and is associated with perturbed endoplasmic reticulum (ER) proteostasis in hepatocytes. In response to chronic ER stress, an adaptive signalling pathway known as the unfolded protein response is triggered to restore ER proteostasis. However, the unfolded protein response can cause inflammation, inflammasome activation and, in the case of non-resolvable ER stress, the death of hepatocytes. Experimental data suggest that the unfolded protein response influences hepatic tumour development, aggressiveness and response to treatment, offering novel therapeutic avenues. Herein, we provide an overview of the evidence linking ER stress to NAFLD and discuss possible points of intervention.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Cell death; Endoplasmic Reticulum Stress; Inflammation; Liver Cancer; Steatohepatitis; Steatosis; Therapeutic Targets; Unfolded Protein Response

Mesh:

Substances:

Year:  2018        PMID: 29940269     DOI: 10.1016/j.jhep.2018.06.008

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  145 in total

1.  Hepatocyte steatosis inhibits hepatitis B virus secretion via induction of endoplasmic reticulum stress.

Authors:  Qichuang Liu; Maoyuan Mu; Huan Chen; Guoyuan Zhang; Yanqing Yang; Jun Chu; Ying Li; Fangwan Yang; Shide Lin
Journal:  Mol Cell Biochem       Date:  2021-05-13       Impact factor: 3.396

2.  C. sakazakii activates AIM2 pathway accompanying with excessive ER stress response in mammalian mammary gland epithelium.

Authors:  Wenjuan Song; Le Sheng; Fanghui Chen; Yu Tian; Lian Li; Genlin Wang; Honglin Li; Yafei Cai
Journal:  Cell Stress Chaperones       Date:  2020-01-10       Impact factor: 3.667

3.  Disruption of Endoplasmic Reticulum Proteostasis in Age-Related Nervous System Disorders.

Authors:  Danilo B Medinas; Younis Hazari; Claudio Hetz
Journal:  Prog Mol Subcell Biol       Date:  2021

4.  Lipid Metabolism and Immune Checkpoints.

Authors:  Qianjin Liao; Yujuan Zhou; Longzheng Xia; Deliang Cao
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  The unfolded protein response and hepatic lipid metabolism in non alcoholic fatty liver disease.

Authors:  Myeong Jun Song; Harmeet Malhi
Journal:  Pharmacol Ther       Date:  2019-08-13       Impact factor: 12.310

6.  The loss-of-function PCSK9Q152H variant increases ER chaperones GRP78 and GRP94 and protects against liver injury.

Authors:  Paul F Lebeau; Hanny Wassef; Jae Hyun Byun; Khrystyna Platko; Brandon Ason; Simon Jackson; Joshua Dobroff; Susan Shetterly; William G Richards; Ali A Al-Hashimi; Kevin Doyoon Won; Majambu Mbikay; Annik Prat; An Tang; Guillaume Paré; Renata Pasqualini; Nabil G Seidah; Wadih Arap; Michel Chrétien; Richard C Austin
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

7.  Fructose stimulated de novo lipogenesis is promoted by inflammation.

Authors:  Jelena Todoric; Giuseppe Di Caro; Saskia Reibe; Darren C Henstridge; Courtney R Green; Alison Vrbanac; Fatih Ceteci; Claire Conche; Reginald McNulty; Shabnam Shalapour; Koji Taniguchi; Peter J Meikle; Jeramie D Watrous; Rafael Moranchel; Mahan Najhawan; Mohit Jain; Xiao Liu; Tatiana Kisseleva; Maria T Diaz-Meco; Jorge Moscat; Rob Knight; Florian R Greten; Lester F Lau; Christian M Metallo; Mark A Febbraio; Michael Karin
Journal:  Nat Metab       Date:  2020-08-24

8.  Genome-wide RNA interference screening reveals a COPI-MAP2K3 pathway required for YAP regulation.

Authors:  Yong Joon Kim; Eunji Jung; Eunbie Shin; Sin-Hyoung Hong; Hui Su Jeong; Gayeong Hur; Hye Yun Jeong; Seung-Hyo Lee; Ji Eun Lee; Gun-Hwa Kim; Joon Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-03       Impact factor: 11.205

Review 9.  Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?

Authors:  Mark A Febbraio; Saskia Reibe; Shabnam Shalapour; Geraldine J Ooi; Matthew J Watt; Michael Karin
Journal:  Cell Metab       Date:  2018-11-15       Impact factor: 27.287

10.  Insulin resistance dysregulates CYP7B1 leading to oxysterol accumulation: a pathway for NAFL to NASH transition.

Authors:  Genta Kakiyama; Dalila Marques; Rebecca Martin; Hajime Takei; Daniel Rodriguez-Agudo; Sandra A LaSalle; Taishi Hashiguchi; Xiaoying Liu; Richard Green; Sandra Erickson; Gregorio Gil; Michael Fuchs; Mitsuyoshi Suzuki; Tsuyoshi Murai; Hiroshi Nittono; Phillip B Hylemon; Huiping Zhou; William M Pandak
Journal:  J Lipid Res       Date:  2020-10-02       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.